BSE filing, NSE: BALPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Bal Pharma Ltd: key numbers
- Share price
- ₹81.85
- Market cap
- ₹130.3 Cr
- Revenue (annual)
- ₹311.7 Cr
- Net profit (annual)
- ₹6.28 Cr
- P/E (TTM)
- 18.1×Sector 45.9×
- Promoter holding
- 50.86%+0.00% QoQ
- FII holding
- 0.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bal Pharma Ltd
All →Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern as mandated under Regulation 31(1)(b) of the SEBI Listing Regulations.
Bal Pharma Dividend
Bal Pharma disbursed its FY25-26 final dividend of ₹1.20 per share on October 9, 2026. Dividends for shareholders with incomplete KYC or bank details have been withheld.
Bal Pharma Management Change
Bal Pharma Limited announced a change in designations for directors Ravindra Kumar Kothari and Virupakshaya Himesh, effective October 1, 2026.
Bal Pharma Annual General Meeting
Bal Pharma Ltd held its 39th Annual General Meeting on September 24, 2026, where shareholders transacted all business items as per the notice.
Bal Pharma Price Movement Clarification
Bal Pharma has clarified that the recent significant movement in its share price is purely market-driven and not due to any undisclosed price-sensitive information.
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern for the period ended March 31, 2026, in compliance with SEBI regulations.
Other capital structure change announcements
All →Rane Holdings Capital Structure Change
Rane Holdings took up 5,15,954 rights shares in its 49%-owned JV, ZF LIFETEC Rane Automotive. No consideration is disclosed, and its stake stays at 49%.
Automobile Corporation Of Goa Capital Structure Change
Automobile Corporation of Goa filed its buyback letter of offer for 1,44,639 shares at Rs 2,005 each. Up to Rs 29.00 Crore tender buyback opens November 3.
- Value
- ₹29.00 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme closed its buyback after purchasing 2,410,906 shares for ₹69.70 Crore. Closure took effect October 30, 2026, ahead of the scheduled period.
- Value
- ₹69.70 Cr
- Execution
- August 14, 2026 to October 30, 2026
Medi Assist Healthcare Services Capital Structure Change
Medi Assist Healthcare's board approved a tender-offer buyback of up to 11,59,199 shares at Rs 425 each, capped at Rs 49.27 Crore. The record date is 20 November 2026, and promoters will not participate.
- Value
- ₹49.27 Cr
KS Smart Technologies Capital Structure Change
KS Smart Technologies called an extraordinary general meeting on 25-Nov-2026 to approve increasing its authorised share capital. The resolution also alters the MoA and AoA clauses.
Bharat Forge Capital Structure Change
Bharat Forge completed a Rs 240 crore rights-issue investment in its wholly owned subsidiary KSSL. KSSL in turn invested Rs 163 crore in its subsidiary AEL.
- Value
- ₹240.0 Cr